Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fff3614f6f67bb0278a8483446d21ceb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeeb8a9d7c825d51a8777faeb5f3abcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba2b54691e41cdaf69b2163f103b2083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91cb71e8755594741fe6a0469afd9973 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b4634d169c53a0a466cfb0b9d496911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 |
filingDate |
1995-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b57c95d277fb5ac57041b47fc5854df2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa7370099606d606695d4644559a305f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46c70f1719a7a29320ba4810c4e3c5fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d47d98114d88fae972905a33ee085e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c406d5b194a6c7e1af1adbe322bdaf |
publicationDate |
1995-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9526401-A1 |
titleOfInvention |
Method for the permanent expression of glutamate receptors |
abstract |
The invention concerns a method for the preparation of eucaryotic cell lines for the permanently ectopic expression of glutamate receptors, the cell lines being prepared by the transformation of cells containing nucleic acids coding for glutamate receptors. The method is characterized in that, during the establishment of the cell lines, at least one of the following conditions is satisfied for the culture: a) the transformed cells are cultured in a culture medium containing a glutamate precursor; b) the transformed cells are cultured in the presence of a glutamate-receptor antagonist; c) the transformed cells are cultured in a first phase under conditions in which glutamate-receptor expression is repressed and in a second phase under conditions in which the repression is discontinued. The invention also concerns the cell lines thus obtained and their use. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5985586-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6956102-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6825322-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7579471-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6033865-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6864358-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6469142-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5849895-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6316611-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6521413-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6376660-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6111091-A |
priorityDate |
1994-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |